NYSE · NTR
Nutrien financials
$71.98−0.35%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.89B | $25.97B | $29.06B | $37.88B | $27.71B | $20.91B | $20.08B | $19.64B |
| Gross profit | $8.35B | $7.53B | $8.47B | $15.42B | $9.41B | $5.24B | $5.50B | $5.39B |
| Gross margin | 31.0% | 29.0% | 29.2% | 40.7% | 34.0% | 25.1% | 27.4% | 27.5% |
| Operating income | $3.44B | $2.22B | $2.84B | $10.81B | $4.78B | $900.0M | $2.08B | $414.0M |
| Net income | $2.27B | $674.0M | $1.26B | $7.66B | $3.15B | $459.0M | $992.0M | $3.57B |
| Net margin | 8.4% | 2.6% | 4.3% | 20.2% | 11.4% | 2.2% | 4.9% | 18.2% |
| Diluted EPS | $4.66 | $1.36 | $2.53 | $14.18 | $5.52 | $0.81 | $1.70 | $5.72 |
| EBITDA | $5.81B | $5.08B | $5.78B | $12.04B | $6.76B | $3.71B | $4.00B | $3.81B |
| Operating cash flow | $4.01B | $3.54B | $5.07B | $8.11B | $3.89B | $3.32B | $3.67B | $2.05B |
| Free cash flow | $2.00B | $1.38B | $2.47B | $5.63B | $2.00B | $1.77B | $1.94B | $647.0M |
| Diluted shares | 486.5M | 494.4M | 497.0M | 540.0M | 571.3M | 569.7M | 583.1M | 624.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $701.0M | $853.0M | $941.0M | $901.0M | $499.0M | $1.45B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $10.74B | $11.45B | $11.24B | $10.72B | $9.63B | $10.22B |
| Total assets | $52.30B | $51.84B | $52.75B | $54.59B | $49.95B | $47.19B |
| Total liabilities | $26.94B | $27.40B | $27.55B | $28.72B | $26.25B | $24.79B |
| Shareholders' equity | $25.36B | $24.44B | $25.20B | $25.86B | $23.70B | $22.40B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology